These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34135787)

  • 1. Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension.
    Olsson KM; Meltendorf T; Fuge J; Kamp JC; Park DH; Richter MJ; Gall H; Ghofrani HA; Ferrari P; Schmiedel R; Kulla HD; Heitland I; Lepsy N; Dering MR; Hoeper MM; Kahl KG
    Front Psychiatry; 2021; 12():667602. PubMed ID: 34135787
    [No Abstract]   [Full Text] [Related]  

  • 2. Haptoglobin Phenotype Among Arab Patients With Mental Disorders.
    Armaly Z; Farhat K; Kinaneh S; Farah J
    J Clin Med Res; 2018 Mar; 10(3):196-201. PubMed ID: 29416577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension.
    Park DH; Fuge J; Meltendorf T; Kahl KG; Richter MJ; Gall H; Ghofrani HA; Kamp JC; Hoeper MM; Olsson KM
    Front Psychiatry; 2021; 12():668647. PubMed ID: 34248706
    [No Abstract]   [Full Text] [Related]  

  • 4. A Population Pharmacokinetic Model of Macitentan and Its Active Metabolite Aprocitentan in Healthy Volunteers and Patients with Pulmonary Arterial Hypertension.
    Bartolucci R; Dosne AG; Csonka D; Pérez-Ruixo JJ; Magni P; Poggesi I
    Clin Pharmacokinet; 2021 Dec; 60(12):1605-1619. PubMed ID: 34159557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry.
    DuBrock HM; Burger CD; Bartolome SD; Feldman JP; Ivy DD; Rosenzweig EB; Sager JS; Presberg KW; Mathai SC; Lammi MR; Klinger JR; Eggert M; De Marco T; Elwing JM; Badesch D; Bull TM; Cadaret LM; Ramani G; Thenappan T; Ford HJ; Al-Naamani N; Simon MA; Mazimba S; Runo JR; Chakinala M; Horn EM; Ryan JJ; Frantz RP; Krowka MJ
    Pulm Circ; 2021; 11(3):20458940211020913. PubMed ID: 34158918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension.
    Cullivan S; Murphy CA; Weiss L; Comer SP; Kevane B; McCullagh B; Maguire PB; Ní Ainle F; Gaine SP
    Pulm Circ; 2021; 11(3):20458940211021036. PubMed ID: 34158919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic database.
    Venkateshvaran A; Seidova N; Tureli HO; Kjellström B; Lund LH; Tossavainen E; Lindquist P
    Int J Cardiovasc Imaging; 2021 Sep; 37(9):2637-2645. PubMed ID: 34146206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience.
    Vlachou M; Fayed H; Dawson A; Reddecliffe S; Stevenson A; Thomson RJ; Schreiber BE; Coghlan JG
    Rheumatology (Oxford); 2022 Mar; 61(3):1106-1114. PubMed ID: 34142120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pulmonary artery pulsatility index predict mortality in pulmonary arterial hypertension?
    Lim Y; Low TT; Chan SP; Lin W; Teo TW; Jang JJ; Kuntjoro I; Tay EL; Yip JW
    ESC Heart Fail; 2021 Oct; 8(5):3835-3844. PubMed ID: 34165259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and non-clinical determinants of pulmonary arterial hypertension development in severe autoimmune rheumatic diseases.
    Arcopinto M; Marra AM
    Rheumatology (Oxford); 2021 Dec; 61(1):1-2. PubMed ID: 34156444
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry.
    Abman SH; Mullen MP; Sleeper LA; Austin ED; Rosenzweig EB; Kinsella JP; Ivy D; Hopper RK; Raj JU; Fineman J; Keller RL; Bates A; Krishnan US; Avitabile CM; Davidson A; Natter MD; Mandl KD;
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34140292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertension.
    Moher Alsady T; Kaireit TF; Behrendt L; Winther HB; Olsson KM; Wacker F; Hoeper MM; Cebotari S; Vogel-Claussen J
    PLoS One; 2021; 16(6):e0251740. PubMed ID: 34138864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study.
    Halimi L; Suehs CM; Marin G; Boissin C; Gamez AS; Vachier I; Molinari N; Bourdin A
    ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34435036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early implementation of renal replacement therapy after lung transplantation does not impair long-term kidney function in patients with idiopathic pulmonary arterial hypertension.
    Benazzo A; Bajorek L; Morscher A; Schrutka L; Schaden E; Klepetko W; Hoetzenecker K;
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):524-535.e3. PubMed ID: 34144824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study.
    Fuge J; Park DH; von Lengerke T; Richter MJ; Gall H; Ghofrani HA; Kamp JC; Hoeper MM; Olsson KM
    Front Psychiatry; 2021; 12():781532. PubMed ID: 35211036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of musculoskeletal pain and its impact on quality of life and functional exercise capacity in patients with pulmonary arterial hypertension.
    Zeren M; Demir R; Sinan UY; Mustafaoglu R; Yildiz A; Kucukoglu MS
    Respir Med; 2022 Mar; 193():106759. PubMed ID: 35134632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life of patients with pulmonary arterial hypertension: a meta-analysis.
    Sarzyńska K; Świątoniowska-Lonc N; Dudek K; Jonas K; Kopeć G; Gajek J; Jankowska-Polańska B
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(15):4983-4998. PubMed ID: 34355370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine.
    Douwes JM; Zijlstra WMH; Rosenzweig EB; Ploegstra MJ; Krishnan US; Haarman MG; Roofthooft MTR; Postmus D; Hillege HL; Ivy DD; Berger RMF
    Ann Am Thorac Soc; 2022 Feb; 19(2):227-237. PubMed ID: 34181866
    [No Abstract]   [Full Text] [Related]  

  • 19. Shifting gears: the search for group 3 pulmonary hypertension treatment.
    Keen JL; Thenappan T
    Curr Opin Pulm Med; 2021 Sep; 27(5):296-302. PubMed ID: 34175858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep apnea and pulmonary hypertension: A riddle waiting to be solved.
    Sharma S; Stansbury R; Hackett B; Fox H
    Pharmacol Ther; 2021 Nov; 227():107935. PubMed ID: 34171327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.